Exact Mass: 1210.5982174

Exact Mass Matches: 1210.5982174

Found 45 metabolites which its exact mass value is equals to given mass value 1210.5982174, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Convallamaroside

2-{[2-({16-[(3,4-dihydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-6-hydroxy-7,9,13-trimethyl-6-[3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-14-yl}oxy)-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C57H94O27 (1210.5982174)

Convallamaroside is a constituent of Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the USA

Notoginsenoside Fc

2-[2-[3-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxane-3,4,5-triol

C58H98O26 (1210.6346008)

Notoginsenoside Fc is found in tea. Notoginsenoside Fc is a constituent of leaves of Panax notoginseng (ginseng) Constituent of leaves of Panax notoginseng (ginseng). Notoginsenoside Fc is found in tea. Notoginsenoside Fc, a protopanaxadiol- (PPD-) type saponin isolated from the leaves of Panax notoginseng, effectively counteracts platelet aggregation. Notoginsenoside Fc can accelerate reendothelialization following vascular injury in diabetic rats by promoting autophagy[1]. Notoginsenoside Fc, a protopanaxadiol- (PPD-) type saponin isolated from the leaves of Panax notoginseng, effectively counteracts platelet aggregation. Notoginsenoside Fc can accelerate reendothelialization following vascular injury in diabetic rats by promoting autophagy[1].

Ginsenoside Ra2

2-{[2-(5-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-16-hydroxy-2,6,6,10,11-pentamethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl)-6-methylhept-5-en-2-yl]oxy}-6-({[4-hydroxy-5-(hydroxymethyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxolan-2-yl]oxy}methyl)oxane-3,4,5-triol

C58H98O26 (1210.6346008)

Ginsenoside Ra2 is found in tea. Ginsenoside Ra2 is from root of Panax ginseng (ginseng From root of Panax ginseng (ginseng). Ginsenoside Ra2 is found in tea.

Ginsenoside Ra1

2-[2-[[17-[2-[6-[[3,4-dihydroxy-5-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-6-methylhept-5-en-2-yl]-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

C58H98O26 (1210.6346008)

Ginsenoside Ra1 is found in tea. Ginsenoside Ra1 is from root of Panax ginseng (ginseng From root of Panax ginseng (ginseng). Ginsenoside Ra1 is found in tea. Ginsenoside Ra1 is a component from ginseng, inhibits protein tyrosine kinase (PTK) activation induced by hypoxia/reoxygenation[1]. Ginsenoside Ra1 is a component from ginseng, inhibits protein tyrosine kinase (PTK) activation induced by hypoxia/reoxygenation[1].

Melongoside L

2-({6-[(3-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-2-{5,7,9,13-tetramethyl-5-oxaspiro[oxane-2,6-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]oxy}oxan-4-yl)oxy]-4,5-dihydroxy-2-methyloxan-3-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C57H94O27 (1210.5982174)

Melongoside L is found in fruits. Melongoside L is a constituent of aubergine (Solanum melongena).

Ginsenoside Ra2

2-[(4,5-dihydroxy-2-{[16-hydroxy-2,6,6,10,11-pentamethyl-14-(6-methyl-2-{[3,4,5-trihydroxy-6-({[4-hydroxy-5-(hydroxymethyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxolan-2-yl]oxy}methyl)oxan-2-yl]oxy}hept-5-en-2-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-yl]oxy}-6-(hydroxymethyl)oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C58H98O26 (1210.6346008)

Ginsenoside Ra1

2-{[2-({14-[2-({6-[({3,4-dihydroxy-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl}oxy)methyl]-3,4,5-trihydroxyoxan-2-yl}oxy)-6-methylhept-5-en-2-yl]-16-hydroxy-2,6,6,10,11-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C58H98O26 (1210.6346008)

Ginsenoside Ra1 is a component from ginseng, inhibits protein tyrosine kinase (PTK) activation induced by hypoxia/reoxygenation[1]. Ginsenoside Ra1 is a component from ginseng, inhibits protein tyrosine kinase (PTK) activation induced by hypoxia/reoxygenation[1].

NotoginsenosideFc

Notoginsenoside Fc

C58H98O26 (1210.6346008)

Notoginsenoside Fc is a natural product found in Panax notoginseng and Panax japonicus with data available. Notoginsenoside Fc, a protopanaxadiol- (PPD-) type saponin isolated from the leaves of Panax notoginseng, effectively counteracts platelet aggregation. Notoginsenoside Fc can accelerate reendothelialization following vascular injury in diabetic rats by promoting autophagy[1]. Notoginsenoside Fc, a protopanaxadiol- (PPD-) type saponin isolated from the leaves of Panax notoginseng, effectively counteracts platelet aggregation. Notoginsenoside Fc can accelerate reendothelialization following vascular injury in diabetic rats by promoting autophagy[1].

Notoginsenoside FP2

(2R,3R,4S,5R,6S)-2-[[(2R,3R,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[2-[(3S,5S,8R,9R,10R,12R,13S,14R,17S)-3-[(2R,3S,4S,5S,6R)-3-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxyoxane-3,4,5-triol

C58H98O26 (1210.6346008)

Agamenoside F

C56H90O28 (1210.561834)

3beta-[(O-beta-D-glucopyranosyl-(1->4)-O-beta-D-diginopyranosyl-(1->4)-O-beta-D-cymaropyranosyl-(1->4)-O-beta-D-cymaropyranosyl-(1->4)-O-beta-D-oleandropyranosyl-(1->4)- beta-D-oleandropyranosyl)oxy]-17-hydroxy-18-norpregna-5,13,15-triene-12,20-dione|amurensioside H

3beta-[(O-beta-D-glucopyranosyl-(1->4)-O-beta-D-diginopyranosyl-(1->4)-O-beta-D-cymaropyranosyl-(1->4)-O-beta-D-cymaropyranosyl-(1->4)-O-beta-D-oleandropyranosyl-(1->4)- beta-D-oleandropyranosyl)oxy]-17-hydroxy-18-norpregna-5,13,15-triene-12,20-dione|amurensioside H

C61H94O24 (1210.6134723999999)

C57H94O27

C57H94O27 (1210.5982174)

hecogenin 3-O-{O-beta-D-glucopyranosyl-(1->2)-O-[O-beta-D-apiofuranosyl-(1->4)-beta-D-glucopyranosyl-(1->3)]-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranoside}

C56H90O28 (1210.561834)

26-O-beta-D-glucopyranosyl-25-R-furost-5-ene-3beta,17alpha,22,6-tetraol-3-O-rhamnosyl-beta-chacotrioside|protopennogenin 3-O-rhamnosyl-beta-chacotrioside

C57H94O27 (1210.5982174)

(25R)-2??-Hydroxyspirost-5-en-3??-yl O-??-D-glucopyranosyl- (1鈥樏傗垎3)-O-??-D-glucopyranosyl-(1鈥樏傗垎2)-O-[??-D-xylopyranosyl-(1鈥樏傗垎3)]-O-??-D-glucopyranosyl-(1鈥樏傗垎4)-??-D-galactopyranoside

(25R)-2??-Hydroxyspirost-5-en-3??-yl O-??-D-glucopyranosyl- (1鈥樏傗垎3)-O-??-D-glucopyranosyl-(1鈥樏傗垎2)-O-[??-D-xylopyranosyl-(1鈥樏傗垎3)]-O-??-D-glucopyranosyl-(1鈥樏傗垎4)-??-D-galactopyranoside

C56H90O28 (1210.561834)

manogenin 3-O-[O-beta-D-glucopyranosyl-(1-2)-O-(O-alpha-L-rhamnopyranosyl-(1-4)-beta-D-xylopyranosyl-(1-3))-O-beta-D-glucopyranosyl-(1-4)-beta-D-galactopyranoside]

C56H90O28 (1210.561834)

(25R)-2-O-((S)-3-hydroxy-3-methylglutaroyl)-5alpha-spirostane-2alpha,3beta,6beta-triol 3-O-{O-beta-D-glucopyranosyl-(1-->2)-O-[beta-D-xylopyranosyl-(1-->3)]-O-beta-D-glucopyranosyl-(1-->4)-beta-D-galactopyranoside}|(25R)-2-O-<(S)-3-hydroxy-3-methylglutaroyl>-5alpha-spirostane-2alpha,3beta,6beta-triol 3-O-2)-O-3)>-O-beta-D-glucopyranosyl-(1-->4)-beta-D-galactopyranoside>

(25R)-2-O-((S)-3-hydroxy-3-methylglutaroyl)-5alpha-spirostane-2alpha,3beta,6beta-triol 3-O-{O-beta-D-glucopyranosyl-(1-->2)-O-[beta-D-xylopyranosyl-(1-->3)]-O-beta-D-glucopyranosyl-(1-->4)-beta-D-galactopyranoside}|(25R)-2-O-<(S)-3-hydroxy-3-methylglutaroyl>-5alpha-spirostane-2alpha,3beta,6beta-triol 3-O-2)-O-3)>-O-beta-D-glucopyranosyl-(1-->4)-beta-D-galactopyranoside>

C56H90O28 (1210.561834)

(25R)-5alpha-spirostan-3beta-yl O-beta-D-glucopyranosyl-(1->2)-O-[O-alpha-L-rhamnopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->3)]-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranoside

C57H94O27 (1210.5982174)

Chromomycin A2

C60H90O25 (1210.577089)

spirost-25(27)-ene-2alpha,3beta-diol 3-O-3)-O-beta-D-glucopyranosyl-(1-->2)-O-3)-O-beta-D-glucopyranosyl-(1-->4)-beta-D-galactopyranoside>|spirost-25(27)-ene-2alpha,3beta-diol 3-O-[O-beta-D-glucopyranosyl-(1-->3)-O-beta-D-glucopyranosyl-(1-->2)-O-[beta-D-xylopyranosyl-(1-->3)-O-beta-D-glucopyranosyl-(1-->4)-beta-D-galactopyranoside]

spirost-25(27)-ene-2alpha,3beta-diol 3-O-3)-O-beta-D-glucopyranosyl-(1-->2)-O-3)-O-beta-D-glucopyranosyl-(1-->4)-beta-D-galactopyranoside>|spirost-25(27)-ene-2alpha,3beta-diol 3-O-[O-beta-D-glucopyranosyl-(1-->3)-O-beta-D-glucopyranosyl-(1-->2)-O-[beta-D-xylopyranosyl-(1-->3)-O-beta-D-glucopyranosyl-(1-->4)-beta-D-galactopyranoside]

C56H90O28 (1210.561834)

26-O-beta-D-glucopyranosyl-3-O-{[beta-D-xylopyranosyl(1->3)][beta-D-galactopyranosyl(1->2)]-beta-D-glucopyranosyl(1->4)-beta-D-glucopyranosyl}-5alpha-furost-20(22)en-12-one-3beta,26-diol

C56H90O28 (1210.561834)

gymnepregoside L

C65H94O21 (1210.6287274)

ginsenoside-Ra2

C58H98O26 (1210.6346008)

(25R)-3??-[(O-??-D-Glucopyranosyl-(1鈥樏傗垎3)-??-D-glucopyranosyl-(1鈥樏傗垎2)-O-[??-D-xylopyranosyl-(1鈥樏傗垎3)]-O-??-D-glucopyranosyl-(1鈥樏傗垎4)-??-D-galactopyranosyl)oxy]-5??-spirostan-12-one

(25R)-3??-[(O-??-D-Glucopyranosyl-(1鈥樏傗垎3)-??-D-glucopyranosyl-(1鈥樏傗垎2)-O-[??-D-xylopyranosyl-(1鈥樏傗垎3)]-O-??-D-glucopyranosyl-(1鈥樏傗垎4)-??-D-galactopyranosyl)oxy]-5??-spirostan-12-one

C56H90O28 (1210.561834)

(3beta,20S,22R,25R,S)-26-(beta-D-glucopyranosyloxy)-22-methoxyfurost-5-en-3-yl beta-D-xylopyranosyl-(1->3)-beta-D-glucopyranosyl-(1->4)[alpha-L-rhamnopyranosyl-(1->2)]-beta-D-glucopyranoside

C57H94O27 (1210.5982174)

ginsenoside-Ra1

C58H98O26 (1210.6346008)

Trigofoenoside G1

C57H94O27 (1210.5982174)

(25R and S)-5alpha-Spirostan-2alpha,3beta,6beta-triol 3-O-beta-D-glucopyranosyl-(1->2)-O-<4-O-(3S)-3-hydroxy-3-methylglutaroyl-beta-D-xylopyranosyl-(1->3)>-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranoside|(25R and S)-5alpha-Spirostan-2alpha,3beta,6beta-triol 3-O-beta-D-glucopyranosyl-(1->2)-O-[4-O-(3S)-3-hydroxy-3-methylglutaroyl-beta-D-xylopyranosyl-(1->3)]-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranoside|(25R)-5alpha-Spirostan-2alpha,3beta,6beta-triol 3-O-beta-D-glucopyranosyl-(1->2)-O-<4-O-(3S)-3-hydroxy-3-methylglutaroyl-beta-D-xylopyranosyl-(1->3)>-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranoside|(25R)-5alpha-Spirostan-2alpha,3beta,6beta-triol 3-O-beta-D-glucopyranosyl-(1->2)-O-[4-O-(3S)-3-hydroxy-3-methylglutaroyl-beta-D-xylopyranosyl-(1->3)]-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranoside|agigenin 3-O-2)-O-<4-O-(S)-3-hydroxy-3-methylglutaryl-beta-D-xylopyranosyl-(1<>3)>-O-beta-D-glucopyranosyl-(1<>4)-beta-D-galactopyranoside>

(25R and S)-5alpha-Spirostan-2alpha,3beta,6beta-triol 3-O-beta-D-glucopyranosyl-(1->2)-O-<4-O-(3S)-3-hydroxy-3-methylglutaroyl-beta-D-xylopyranosyl-(1->3)>-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranoside|(25R and S)-5alpha-Spirostan-2alpha,3beta,6beta-triol 3-O-beta-D-glucopyranosyl-(1->2)-O-[4-O-(3S)-3-hydroxy-3-methylglutaroyl-beta-D-xylopyranosyl-(1->3)]-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranoside|(25R)-5alpha-Spirostan-2alpha,3beta,6beta-triol 3-O-beta-D-glucopyranosyl-(1->2)-O-<4-O-(3S)-3-hydroxy-3-methylglutaroyl-beta-D-xylopyranosyl-(1->3)>-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranoside|(25R)-5alpha-Spirostan-2alpha,3beta,6beta-triol 3-O-beta-D-glucopyranosyl-(1->2)-O-[4-O-(3S)-3-hydroxy-3-methylglutaroyl-beta-D-xylopyranosyl-(1->3)]-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranoside|agigenin 3-O-2)-O-<4-O-(S)-3-hydroxy-3-methylglutaryl-beta-D-xylopyranosyl-(1<*>3)>-O-beta-D-glucopyranosyl-(1<*>4)-beta-D-galactopyranoside>

C56H90O28 (1210.561834)

Dongnoside B

C57H94O27 (1210.5982174)

filicinin-B

C57H94O27 (1210.5982174)

Tigogenin-3-O-??-L-rhamnopyranosyl-(1鈥樏傗垎3)-??-D-glucopyranosyl(1鈥樏傗垎2)-[??-D-glucopyranosyl(1鈥樏傗垎3)]-??-D-glucopyranosyl(1鈥樏傗垎4)-??-D-galactopyranoside

C57H94O27 (1210.5982174)

26-O-beta-D-glucopyranosyl(25R)-furost-5-ene-3beta,22alpha,26-triol 3-O-alpha-L-rhamnopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->4)-[alpha-L-rhamnopyranosyl-(1->2)]-beta-D-glucopyranoside

C57H94O27 (1210.5982174)

lipid Q

C58H98O26 (1210.6346008)

costusoside J

C57H94O27 (1210.5982174)

Caffeoyl hydroxy tomatidine-tri-O-hexosyl-O-pentoside

C60H90O25 (1210.577089)

Notoginsenoside Fc

2-[(2-{5-[(3-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]-16-hydroxy-2,6,6,10,11-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}-6-methylhept-5-en-2-yl)oxy]-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxane-3,4,5-triol

C58H98O26 (1210.6346008)

Notoginsenoside Fc, a protopanaxadiol- (PPD-) type saponin isolated from the leaves of Panax notoginseng, effectively counteracts platelet aggregation. Notoginsenoside Fc can accelerate reendothelialization following vascular injury in diabetic rats by promoting autophagy[1]. Notoginsenoside Fc, a protopanaxadiol- (PPD-) type saponin isolated from the leaves of Panax notoginseng, effectively counteracts platelet aggregation. Notoginsenoside Fc can accelerate reendothelialization following vascular injury in diabetic rats by promoting autophagy[1].

Melongoside L

2-{[6-({4-[(3,4-dihydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-5-hydroxy-6-(hydroxymethyl)-2-{5,7,9,13-tetramethyl-5-oxaspiro[oxane-2,6-pentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane]oxy}oxan-3-yl}oxy)-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C57H94O27 (1210.5982174)